OMID Holdings

OMID

Drug Manufacturers - Specialty & Generic · Healthcare

Price

$0.02

+0.00 (+0.00%)

Market Cap

$2.1M

Winston Score

Winston is worried

Below-average fundamentals — multiple weak pillars.

Data as of Aug 23, 2026 · filings through Dec 31, 2025

How the score breaks down

Quality

Weak

Growth

Mixed

Cash Flow

Weak

Stability

Weak

Valuation

Data not available

Track this stock — start free trial

Share count falling — buybacks

−44.9% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 174.8M (2021) → 96.3M (2025)

Winston Score History

The full picture

OMID Holdings is a small healthcare company focused on developing specialty pharmaceutical products. It works on drug treatments aimed at serious medical conditions, targeting patients and healthcare providers as its end customers. The company operates in the specialty and generic drug manufacturing industry, where it is in early stages compared to larger, established pharmaceutical firms.

OMID Holdings generates little to no revenue at this stage, as it has not yet brought significant commercial products to market. It operates primarily in the United States and has a very small market presence, reflected in its near-zero market capitalization and deeply negative margins. The central risk facing the company is its ability to fund ongoing operations and advance its drug pipeline through clinical development and regulatory approval, without which it cannot reach profitability.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+3.4% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+113.8% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

100.0%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

5+ years

Quarterly Free Cash Flow

→ Burn rate stable

$292,044 cash & investments at current burn rate

Growth context

OMID Holdings is growing revenue at 3% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

42.5%

Healthy — 42.5% gross margin

Profit after running costs

Operating Margin

-47.7%

Losing money on operations — -47.7%

Return on the money invested

ROCE

-78.1%

Weak — -78.1% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+59.2%

Fast-growing sales (+59.2% YoY)

Profit growth

EPS YoY

N/A

Data not available

How steady the profit is

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

-33.0%

Burning cash (-33.0%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

4.05

Heavy debt load (4.05)

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial